Palvella Therapeutics PVLA Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Palvella Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Palvella Therapeutics's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Palvella Therapeutics's change in other assets?
- Palvella Therapeutics (PVLA) reported change in other assets of $357K in Q1 2026.
- How has Palvella Therapeutics's change in other assets changed year-over-year?
- Palvella Therapeutics's change in other assets increased by 143.6% year-over-year, from -$819K to $357K.
- What is the long-term trend for Palvella Therapeutics's change in other assets?
- Over 4 years (2021 to 2025), Palvella Therapeutics's change in other assets has grown at a -18.9% compound annual growth rate (CAGR), from $3.15M to -$1.36M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.